Featured Publications

MYC protein interactors in gene transcription and cancer

MYC protein interactors in gene transcription and cancer

Lourenco C, Resetca D, Redel C, Lin P, MacDonald AS, Ciaccio R, Kenney TMG, Wei Y, Andrews DW, Sunnerhagen M, Arrowsmith CH, Raught B, Penn LZ. MYC protein interactors in gene transcription and cancer. Nat Rev Cancer. 2021 Jun 29. doi: 10.1038/s41568-021-00367-9. Epub ahead of print.

Read More

An amphipathic Bax core dimer forms part of the apoptotic pore wall in the mitochondrial membrane

An amphipathic Bax core dimer forms part of the apoptotic pore wall in the mitochondrial membrane

Lv F, Qi F, Zhang Z, Wen M, Piai A, Du L, Zhou L, Yang Y, Wu B, Liu Z, Rosario J, Pogmore JP, Chou JJ, Andrews DW, Jin J, Yang BO. An amphipathic Bax core dimer forms part of the apoptotic pore wall in the mitochondrial membrane. EMBO Journal. 2021 Jun 8:e106438. doi: 10.15252/embj.2020106438.    

Read More

Pharmacological Targeting of Executioner Proteins: Controlling Life and Death

Pharmacological Targeting of Executioner Proteins: Controlling Life and Death

Pogmore JP, Uehling D, Andrews DW. Pharmacological Targeting of Executioner Proteins: Controlling Life and Death. J Med Chem. 2021 May 13;64(9):5276-5290. doi: 10.1021/acs.jmedchem.0c02200.

Read More

Allosteric Regulation of BH3 Proteins in Bcl-xL Complexes Enables Switch-like Activation of Bax

Allosteric Regulation of BH3 Proteins in Bcl-xL Complexes Enables Switch-like Activation of Bax

Bogner C, Kale J, Pogmore J, Chi X, Shamas-Din A, Fradin C, Leber B, Andrews DW. Allosteric Regulation of BH3 Proteins in Bcl-xL Complexes Enables Switch-like Activation of Bax. Mol Cell. 2020 Feb 20;77(4):901-912.e9. doi: 10.1016/j.molcel.2019.12.025.

Read More

Nature Webinar – Understanding cancer drug responses, efficacy and resistance using high-content screening

Nature Webinar – Understanding cancer drug responses, efficacy and resistance using high-content screening

Nature Webinar – Understanding cancer drug responses, efficacy and resistance using high-content screening  

Read More

Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2

Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2

Liu Q, Oesterlund EJ, Chi X, Pogmore J, Leber B, Andrews D.W., Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2. (2019). Elife. 8:e37689. doi: 10.7554/eLife.37689.

Read More